arrow_back Back to App

Strengthening US Drug Manufacturing for Better Health Preparedness

This act aims to improve the United States' ability to quickly produce medicines and other medical products during crises. This means citizens can expect faster access to essential supplies in health emergencies, enhancing national security and readiness.
Key points
Reviewing current US drug manufacturing capabilities to identify weaknesses.
Developing plans and technologies for rapid production adaptation to new threats.
Strengthening domestic drug production, reducing reliance on foreign suppliers in critical times.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3553
Sponsor: Sen. Rubio, Marco [R-FL]
Process start date: 2022-02-02